EW
Edwards Lifesciences Corp.
Is EW Halal?
Life-preserving heart-valve and critical-care devices are generally permissible, and the current asset-based financial ratios pass while product-specific questions remain.
What You Should Know
Edwards Lifesciences' March 31, 2026 filing reports debt/assets of 4.49%, cash plus identifiable debt securities/assets of 27.90%, receivables plus cash/assets of 25.66% and disclosed net interest income/revenue of 2.03%. Its transcatheter and surgical heart valves and critical-care technologies generally support preservation of life, while bovine tissue, clinical use, access and acquisition exposure require qualitative review.
⚠️ Concerns
- •Some heart valves use bovine pericardial tissue; necessity and transformation are scholar- and product-specific
- •Net interest income is disclosed but no universal purification percentage is prescribed
- •The Autus acquisition and investment impairments can change product and financial exposure
- •Clinical evidence, safety, access, pricing and regulatory obligations require continuing review
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.
598.5 / 13,321.2
3,715.6 / 13,321.2
3,418.5 / 13,321.2
33.5 / 1,648.6
- Financial
- Pass
- Overall
- Incomplete
Debt is 4.49%, cash plus identifiable debt securities are 27.90%, receivables plus cash are 25.66% and disclosed net interest income is 2.03%; the examined financial ratios pass, while product materials and clinical-use questions remain qualitatively incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt is 4.49%, liquidity is 27.90% and receivables plus cash are 25.66%, below the examined MSCI total-assets limits. This is a calculation against the named method, not an index-membership claim.
- Financial
- Pass
- Overall
- Incomplete
Debt is 4.49% and liquidity is 27.90%, below the examined Malaysia SAC financial limits. This is a calculation against SAC ratios, not an official classification of a U.S.-listed security.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Edwards Lifesciences develops transcatheter and surgical heart valves, transcatheter mitral and tricuspid therapies and critical-care technologies. Medical devices that treat disease and preserve life are generally permissible, while animal-derived materials, clinical use and product-specific evidence require continuing review.
Limitation: The filing does not allocate revenue by biological material, procedure, clinical use or customer contract into a universal prohibited-revenue numerator; no blanket zero-concern claim is made.
Purification
Edwards discloses net interest income but does not prescribe a scholar-approved purification percentage. Readers should follow the qualified scholar or methodology they use rather than applying an invented fixed rate.
Inputs, assumptions and primary sources
- Inputs use Edwards Lifesciences' March 31, 2026 Form 10-Q; amounts are USD millions as presented in the filing.
- Debt uses the $598.5 million carrying value of the 4.3% senior notes; no revolving-credit balance was outstanding. Operating lease liabilities are not entered as conventional debt.
- Cash uses $2,445.5 million of cash and cash equivalents. Interest-bearing securities use $1,270.1 million of disclosed debt securities, including held-to-maturity bank time deposits and available-for-sale commercial paper, government and agency, asset-backed and corporate debt securities.
- Receivables use $775.7 million of accounts receivable plus $197.3 million of other receivables reported on the balance sheet.
- Quarterly net sales are $1,648.6 million and disclosed net interest income is $33.5 million. No fixed purification percentage is prescribed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →